Brief Report: Preventing Infusion-related Reactions with Intravenous Amivantamab: Results from SKIPPirr, a Phase 2 Study

Alexander I. Spira,Luis Paz-Ares,Ji-Youn Han, Jin-Yuan Shih,Céline Mascaux,Upal Basu Roy,Jon Zugazagoitia,Yu Jung Kim,Chao-Hua Chiu, Sang-We Kim,Ernest Nadal, Ignacio Gil-Bazo, Sean P. Murphy, Bailey G. Anderson, Yichuan Xia, George Wang, Joshua M. Bauml, Marc Chioda, Jairo Simoes, Parthiv J. Mahadevia

Journal of Thoracic Oncology（2025）

Cited 0|Views5

Key words

amivantamab,dexamethasone,infusion-related reactions,NSCLC,prophylaxis

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined